The disease presentation was atypical in the proband who had neonatal hypoglycemia on the 3rd day of life (glucose level was 2.1 mmol/L), and despite developing diabetes at 5 months, did not start insulin treatment until 2 years of age. This evidence concerns the gene INS and Hypoglycemia.